Alpha-MSH vs Melanotan II

Alpha-MSH wins for closely mimicking endogenous signaling, ultra-short duration of action (minutes), and minimal cumulative receptor activation — ideal for mechanistic studies and situations demanding tight, transient control. Its side-effect profile is extremely mild due to lower effective exposure, and there's almost no lingering effect after dosing ceases.

Melanotan II wins for practical pigmentation (tanning), sexual enhancement, and long-lasting melanocortin activity. MT-II brings far greater potency, real-world efficacy in building and sustaining a tan, and a much more pronounced pro-libido/erectile impact at per-injection doses two orders of magnitude lower than the mass of pure α-MSH. Pigment build persists weeks post-cycle and is far more UV-efficient. Sourcing and protocol templates are widely covered in the looksmaxxing community.

Pick Alpha-MSH if:

• A mechanistic research protocol requires tight temporal control over melanocortin activation (minute-to-minute resolution)
• Minimal side effect profile is critical, and pigment changes must be subtle and transient
• Modeling the exact endogenous response for binding studies or ex vivo work
• Ultimate goal is MC receptor mapping, not aesthetics or sexual endpoints
• Looking to avoid cumulative alteration of pigmentation/mole profile

Pick Melanotan II if:

• The protocol requires maximal visible tanning with minimal UV exposure
• Libido boost and pro-erectile effects are part of the study endpoint
• A sustained, easily-titrated melanocortin effect is desired (single injection builds multi-day effect)
• The available literature and user protocols (e.g. dosing schedules, side effect management) are important for protocol reproducibility
• Cosmetic endpoint (tan depth/tone) is prioritized above pure mechanistic precision